Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring

Haematologica. 2015 Mar;100(3):e93-6. doi: 10.3324/haematol.2014.115725. Epub 2014 Nov 25.

Affiliations

¹ Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Medizinische Fakultät, Germany.
² VU University Medical Center Amsterdam, The Netherlands.
³ Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden, Medizinische Fakultät, Germany uwe.platzbecker@uniklinikum-dresden.de.

No abstract available

Keywords: MDS; del(5q); immunophenotypic profile.

Publication types

Letter

MeSH terms

Antigens, CD / genetics
Antigens, CD / immunology
Bone Marrow / drug effects
Bone Marrow / immunology
Bone Marrow / pathology
Chromosome Deletion*
Chromosomes, Human, Pair 5*
Cohort Studies
Drug Monitoring
Female
Gene Expression
Humans
Immunologic Factors / therapeutic use*
Immunophenotyping
Lenalidomide
Lymphocytes / drug effects
Lymphocytes / immunology
Lymphocytes / pathology
Male
Myelodysplastic Syndromes / diagnosis
Myelodysplastic Syndromes / drug therapy*
Myelodysplastic Syndromes / genetics
Myelodysplastic Syndromes / immunology
Myeloid Cells / drug effects
Myeloid Cells / immunology
Myeloid Cells / pathology
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Antigens, CD
Immunologic Factors
Thalidomide
Lenalidomide